Purified peanut protein extract + peanut for peanut hypersensitivity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Jun 2013: Trial registered, NCT01867671
  2. 13 Aug 2013: Trial started, NCT01867671

The trials

NCT01867671: Peanut Oral Immunotherapy in Children

State
Completed
Phase
Phase 2
People
146 taking part
Started
13 Aug 2013
Primary completion
2 Jul 2018
Arms
Peanut Oral Immune Therapy (OIT)
Results
Posted on the registry
  1. 4 Jun 2013: Trial registered
  2. 13 Aug 2013: Trial started
  3. 21 Dec 2018: Trial completed
  4. 22 Jan 2020: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.